Dr. Goldsmith is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1405 Clifton Road
Children's Healthcare of Atlanta
Atlanta, GA 30322Phone+1 404-785-1200- Is this information wrong?
Education & Training
- Children's Hospital of PhiladelphiaFellowship, Pediatric Hematology/Oncology, 2002 - 2005
- Children's Hospital of PhiladelphiaResidency, Pediatrics, 1999 - 2002
- University of Alabama School of MedicineClass of 1999
Certifications & Licensure
- GA State Medical License 2009 - 2025
- PA State Medical License 2000 - 2010
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- N2012-01: Phase 1 Study of Difluoromethylornithine (DFMO) and Celecoxib With Cyclophosphamide/Topotecan Start of enrollment: 2014 Jan 16
- 131I-MIBG Alone VS. 131I-MIBG With Vincristine and Irinotecan VS131I-MIBG With Vorinostat Start of enrollment: 2014 Jul 01
- MIBG With Dinutuximab +/- Vorinostat Start of enrollment: 2018 Sep 12
Roles: Contact
- Join now to see all
Publications & Presentations
PubMed
- 47 citationsMitochondrial Bcl-2 Family Dynamics Define Therapy Response and Resistance in NeuroblastomaKelly C. Goldsmith, Michelle Gross, Susan K. Peirce, Dema Luyindula, Xueyuan Liu
Cancer Research. 2012-05-15 - 45 citationsAccelerating drug development in pediatric cancer: a novel Phase I study design of venetoclax in relapsed/refractory malignancies.Andrew E. Place, Kelly C. Goldsmith, Jean-Pierre Bourquin, Mignon L. Loh, Lia Gore
Future Oncology. 2018-03-29 - 6 citationsMentors' perspectives on the successes and challenges of mentoring in the COG Young Investigator mentorship program: A report from the Children's Oncology GroupAdam J. Esbenshade, Lisa S. Kahalley, Reto M. Baertschiger, Roshni Dasgupta, Kelly C. Goldsmith
Pediatric Blood & Cancer. 2019-07-16
Press Mentions
- Clinical Trial May Change the Paradigm of Care for Patients with ALK-Driven High-Risk NeuroblastomaApril 4th, 2023
- Researchers Show Lorlatinib Is Safe and Effective for Patients with ALK-Driven Relapsed/Refractory High-Risk NeuroblastomaMarch 31st, 2023
- Targeted Cancer Treatment Helps Georgia Boy Facing Advanced NeuroblastomaOctober 5th, 2022
- Join now to see all
Hospital Affiliations
- Children's Healthcare of AtlantaAtlanta, Georgia
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: